Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial

CMAJ. Canadian Medical Association Journal

Volumn 186, Issue 8, 2014, Pages 577-584

  McAlister, Finlay A ^a   Majumdar, Sumit R ^a   Padwal, Raj S ^a   Fradette, Miriam ^a   Thompson, Ann ^a   Buck, Brian ^b   Dean, Naeem ^a,b   Bakal, Jeffrey A ^a   Tsuyuki, Ross ^a   Grover, Steven ^c   Shuaib, Ashfaq ^b  

^a ROYAL ALEXANDRA HOSPITAL   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CASE MANAGEMENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DYSLIPIDEMIA; FEMALE; GENERAL PRACTITIONER; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NURSE; OUTCOME ASSESSMENT; PATIENT COUNSELING; PHARMACIST; PRESCRIPTION; PREVENTION STUDY; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TRANSIENT ISCHEMIC ATTACK;

AGED; AGED, 80 AND OVER; ANTICHOLESTEREMIC AGENTS; ANTIHYPERTENSIVE AGENTS; CASE MANAGEMENT; CHOLESTEROL, LDL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PREVENTIVE MEDICINE; PROSPECTIVE STUDIES; RECURRENCE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; STROKE; TREATMENT OUTCOME;

EID: 84900400567     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.140053     Document Type: Article

References (31)

1. Kaplan RC, Tirschwell DL, Longstreth WT, et al. Vascular events, mortality, and preventive therapy following ischemic stroke in the elderly. Neurology 2005;65:835-42. (Pubitemid 41362125)
2. Webster F, Saposnik G, Kapral MR, et al. Organized outpatient care: stroke prevention clinic referrals are associated with reduced mortality after transient ischemic attack and ischemic stroke. Stroke 2011;42:3176-82.
3. O'Donnell MJ, Xavier D, Liu L, et al.; INTERSTROKE investigators. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010;376:112-23.
4. Straus SE, Majumdar SR, McAlister FA. New evidence for stroke prevention: scientific review. JAMA 2002;288:1388-95. (Pubitemid 35025911)
5. Hackam DG, Spence JD. Combining multiple approaches for the secondary prevention of vascular events after stroke: a quantitative modeling study. Stroke 2007;38:1881-5. (Pubitemid 46847263)
6. Zhang H, Thijs L, Staessen JA. Blood pressure lowering for primary and secondary prevention of stroke. Hypertension 2006; 48:187-95. (Pubitemid 44321393)
7. Baigent C, Keech A, Kearney PM, et al. Cholesterol Treatment Trialists Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins. Lancet 2005;366:1267-78.
8. Mouradian MS, Majumdar SR, Senthilselvan A, et al. How well are hypertension, hyperlipidemia, diabetes, and smoking managed after a stroke or transient ischemic attack? Stroke 2002; 33:1656-9. (Pubitemid 34619974)
9. Joseph LN, Babikian VL, Allen NC, et al. Risk factor modification in stroke prevention. The experience of a stroke clinic. Stroke 1999; 30:16-20. (Pubitemid 29029435)
10. Roumie CL, Ofner S, Ross JS, et al. Prevalence of inadequate blood pressure control among veterans after acute ischemic stroke hospitalization: a retrospective cohort. Circ Cardiovasc Qual Outcomes 2011;4:399-407.
11. Majumdar SR, McAlister FA, Furberg CD. From publication to practice in chronic cardiovascular disease- the long and winding road. J Am Coll Cardiol 2004;43:1738-42. (Pubitemid 38622507)
12. Clark AM, Hartling L, Vandermeer B, et al. Meta-analysis: secondary prevention programs for patients with coronary artery disease. Ann Intern Med 2005;143:659-72.
13. Shojania KG, Ranji SR, McDonald KM, et al. Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis. JAMA 2006;296:427-40. (Pubitemid 44127527)
14. Carter BL, Rogers M, Daly J, et al. The potency of team-based care interventions for hypertension: a meta-analysis. Arch Intern Med 2009;169:1748-55.
15. Santschi V, Chiolero A, Burnand B, et al. Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials. Arch Intern Med 2011;171:1441-53.
16. Glynn LG, Murphy AW, Smith SM, et al. Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev 2010;(3):CD005182.
17. McAlister FA, Majumdar SR, Padwal RS, et al. The preventing recurrent vascular events and neurological worsening through intensive organized case-management (PREVENTION) Trial protocol [clinicaltrials.gov identifier: NCT00931788]. Implement Sci 2010;5:27.
18. McLean DL, McAlister FA, Johnson JA, et al. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN). Arch Intern Med 2008; 168: 2355-61.
19. Lindsay P, Bayley M, McDonald A, et al. Toward a more effective approach to stroke: Canadian Best Practice Recommendations for Stroke Care. CMAJ 2008;178:1418-25. (Pubitemid 351775717)
20. Vernooij JW, Kaasjager HA, van der Graaf Y; SMART Study Group. Internet based vascular risk factor management for patients with clinically manifest vascular disease: randomised controlled trial. BMJ 2012;344:e3750.
21. Margolis KL, Asche SE, Bergdall AR, et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA 2013;310:46-56.
22. Magid DJ, Olson KL, Billups SJ, et al. A pharmacist-led, American Heart Association Heart360 Web-enabled home blood pressure monitoring program. Circ Cardiovasc Qual Outcomes 2013; 6:157-63.
23. Kerry SM, Markus HS, Khong TK, et al. Home blood pressure monitoring with nurse-led telephone support among patients with hypertension and a history of stroke: a community-based randomized controlled trial. CMAJ 2013;185:23-31.
24. Wolfe CD, Redfern J, Rudd AG, et al. Cluster randomized controlled trial of a patient and general practitioner intervention to improve the management of multiple risk factors after stroke: stop stroke. Stroke 2010;41:2470-6.
25. Ellis G, Rodger J, McAlpine C, et al. Impact of stroke nurse specialist input on risk factor modification: a randomized controlled trial. Age Ageing 2005;34:389-92. (Pubitemid 41511323)
26. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009;338:b1665.
27. Amarenco P, Goldstein LB, Szarek M. Effects of intense lowdensity lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke 2007; 38:3198-204. (Pubitemid 350175737)
28. Rothwell PM, Giles MF, Chandratheva A, et al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison [published erratum in Lancet 2008;371:386]. Lancet 2007;370:1432-42. (Pubitemid 47576154)
29. Brown LC, Johnson JA, Majumdar SR, et al. Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis. CMAJ 2004; 171:1189-92. (Pubitemid 39518012)
30. Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006;295:180-9. (Pubitemid 43076437)
31. McAlister FA, Fradette M, Majumdar SR, et al. The Enhancing Secondary Prevention in Coronary Artery Disease trial. CMAJ 2009;181:897-904.